Does CVS Caremark Cover Zepbound? (2026 Coverage Update)
By The RX Index Editorial Team — a pricing intelligence and comparison resource for GLP-1 telehealth providers. Last verified:
Does CVS Caremark cover Zepbound? For its three main commercial drug lists — the Standard Control, Advanced Control, and Value formularies — no, not right now. Zepbound was removed on July 1, 2025. But here’s the update most pages haven’t caught up to: on May 28, 2026, CVS Health announced Zepbound is coming back as a preferred option on October 1, 2026 — for plan sponsors who choose to cover it.
So the honest answer is: not on most standard plans today, but soon, and only if your employer adopts the change. This page tells you exactly how to check.
The quick verdict
| Your question | The straight answer |
|---|---|
| Does CVS Caremark cover Zepbound today? | Not on its standard commercial lists — Zepbound came off them on July 1, 2025. Some custom employer plans kept it. |
| Is that changing? | Yes. CVS says Zepbound returns as a preferred option on October 1, 2026, for plans that elect coverage. |
| Will every member get it then? | No. Your employer (the “plan sponsor”) still decides whether to cover it. |
| Will I need approval first? | Very likely. CVS Caremark has prior-authorization rules for weight loss, sleep apnea, and renewals. |
| What if I’m told “not covered”? | Get the reason in writing, then pick one of three routes: appeal, the sleep-apnea path, or pay cash through Lilly (~$299–$449/mo). |
| Fastest first step | Check your own plan on caremark.com — or run a free GLP-1 coverage check that contacts your plan for you. |
Not sure where your plan stands?
Take our free 60-second matching quiz and get a personalized CVS Caremark + Zepbound action plan — what to check, what to ask, and what it’ll cost for your situation.
Start the free quiz →No account, no card.
Does CVS Caremark cover Zepbound right now?
So the answer comes down to two things: timing and your specific plan.
If you’re checking before October 1, 2026:
Most standard plans will show Zepbound as not covered, non-formulary, or Wegovy preferred. A few custom employer plans kept Zepbound the whole time, so check yours instead of assuming.
If you’re checking on or after October 1, 2026:
Zepbound should be back as a preferred option if your employer adopts the updated list. You may still need approval first.
Why two people who “have CVS Caremark” can get completely different answers
CVS Caremark is a PBM — a pharmacy benefit manager, the company that runs the drug side of your insurance. It builds the drug list. But your employer picks which version of that list you get, and can customize it.
CVS says plainly: plan sponsors keep the right to decide whether to cover GLP-1 medications for weight loss. “CVS is bringing it back” is not the same as “your plan will pay for it tomorrow.” You have to check your own plan.
What changed with CVS Caremark and Zepbound? (the full timeline)
| When | What happened | Source |
|---|---|---|
| May 2025 | CVS Caremark moved toward making Wegovy its preferred weight-loss GLP-1 | News reporting |
| July 1, 2025 | Zepbound removed from the Standard Control, Advanced Control, and Value formularies. Existing Zepbound PAs were transferred to Wegovy. | CVS Caremark plan notices |
| Sept. 2025 | A proposed class-action lawsuit was filed over the coverage change | Fierce Healthcare |
| Late 2025–early 2026 | Some custom employer plans kept Zepbound; standard plans did not | Plan-level reporting |
| May 28, 2026 | CVS Health announced Zepbound returns as a preferred option on common commercial lists | CVS Health press release |
| June 1, 2026 | CVS removed the block on Foundayo (Lilly’s new oral GLP-1 pill), where plans allow it | CVS Health |
| Oct. 1, 2026 | Zepbound is added back as an additional preferred option for plans that elect coverage. CVS says its standard commercial template covers roughly 25–30 million people. | CVS Health |
Two things worth knowing. First, the switch sparked real anger — many patients said publicly they did better on Zepbound than on Wegovy, and news outlets tied the May 2026 reversal to that backlash.
Second, Zepbound is coming back as an additional preferred option, not a replacement for Wegovy. Both can be preferred at the same time. That’s actually good news: the plan won’t be steering you to one drug at the list level anymore.
How do you check whether your CVS Caremark plan covers Zepbound?
- 1
Log in at caremark.com (or the CVS Caremark app)
- 2
Open "Check Drug Cost" or "Drug Coverage."
- 3
Search Zepbound, and pick the exact form: single-dose pen, single-dose vial, or KwikPen.
- 4
Read the status word carefully (see the decoder below).
- 5
Call the number on your pharmacy card and ask them to confirm it in writing.
- 6
Ask your HR or benefits team: "Did our plan adopt the October 1, 2026 GLP-1 update, and are weight-loss drugs covered or excluded?"
Save these five things for your doctor or an appeal:
- The drug name and dose/form
- The exact status word the portal shows
- The copay estimate
- Any “PA / quantity limit / step therapy” note
- The date you checked
Coverage status decoder — what the portal word means and what to do
| If the portal says… | It usually means… | Your move |
|---|---|---|
| Covered | The plan may pay, but you’ll still owe a copay or deductible | Check the dose, the quantity limit, and which pharmacy |
| Prior authorization required | Your doctor must send documentation before the plan pays | Build your PA packet (next section) before the request goes in |
| Quantity limit | The plan caps how much you can get per fill | Make sure your prescribed dose and form fit the limit |
| Non-formulary | Not on the preferred list, but an exception may be possible | Ask about the formulary exception process |
| Excluded / not covered | Your benefit may not cover the drug at all | Get the denial in writing; compare appeal vs. cash pay |
| Wegovy preferred | The plan wants you to try Wegovy first | Talk to your doctor about whether to switch or push for an exception |
Don’t want to sit on hold or decode insurance fine print?
Ro offers a free GLP-1 Insurance Coverage Checker — you enter your insurance details, Ro’s team works with your plan, and they email you a personalized report showing whether Zepbound is covered, what it’ll cost, and whether prior authorization is required. New Ro accounts also get a $50 credit.
Check your Zepbound coverage free →Sponsored option. A clinician visit is required before any prescription.
What should you ask CVS Caremark or your HR team before your doctor submits Zepbound?
Ask whether your plan:
- •Uses CVS Caremark's standard template or a custom list
- •Adopted the October 1, 2026 Zepbound update
- •Covers weight-loss drugs or excludes them
- •Has a specific prior-authorization form for Zepbound
If HR says “covered with prior authorization”
You’re in good shape — just need the right paperwork. Go to the PA section below.
If HR says weight-loss drugs are “excluded”
That’s a benefit-design choice. No appeal can force coverage — but cash-pay routes exist. See the cost section below.
What does CVS Caremark require for Zepbound prior authorization?
Path 1: Starting Zepbound for weight loss
Your doctor will generally need to show:
- A BMI of 30 or higher, or a BMI of 27 or higher plus a weight-related health condition — like type 2 diabetes, high blood pressure, high cholesterol, heart disease, or sleep apnea
- That you’re using the medicine with a reduced-calorie diet and more physical activity
- Documentation that you took part in a comprehensive weight-management program — diet, activity, and behavior change — generally for at least six months before starting
During the gap: expect a Wegovy detour
Because Wegovy has been CVS Caremark’s preferred weight-loss GLP-1, getting Zepbound covered usually meant requesting a formulary exception, and many plans wanted to see that you’d tried Wegovy first or couldn’t use it. Follow the exact trial length and “didn’t work” definition written in your own plan’s criteria or denial letter. This may ease after October 1, 2026 as Zepbound rejoins the preferred list.
Path 2: Moderate-to-severe sleep apnea (OSA)
This is the path a lot of people don’t know about. Zepbound is FDA-approved to treat moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity. Because this is a separate, approved use, it can open a different coverage door.
For the OSA path, CVS Caremark’s rules generally want:
- A diagnosis of moderate-to-severe OSA (clinically, that usually means an AHI of 15 or higher — confirmed by a sleep study)
- A BMI of 30 or higher
- The same diet-and-activity documentation
It is not an automatic yes. But if you genuinely have OSA, this is worth raising with your doctor.
Path 3: Renewing an existing prescription
To keep covering Zepbound, CVS Caremark’s continuation criteria generally look for at least three months at a stable maintenance dose plus at least 5% weight loss from your starting weight (or that you’ve kept off the first 5% you lost). Track your baseline weight from day one.
One more thing: quantity limits
Even after you’re approved, CVS Caremark sets quantity limits on how much you can fill at once. “Approved” doesn’t always mean “fill as much as you want.” Make sure your dose and pharmacy line up with the limit.
Don’t want to risk a denial on a missing document?
Use our free quiz to get a PA checklist built for your situation — BMI and condition fields, the comprehensive-program note, the OSA option, and the renewal proof your plan looks for.
Or, if you’d rather hand it off, Ro’s licensed providers can prescribe Zepbound and Ro’s insurance team files the prior authorization for you.
The Ro path is sponsored. Approval is never guaranteed.
What should you do if CVS Caremark says Zepbound is “not covered”?
Most denials fall into one of two buckets. Fixable denials come from a missing document, the wrong indication, step-therapy wording, or a quantity-limit issue — those you can often resolve by resubmitting with the right paperwork. A plan exclusion is different: that usually means an HR or benefits conversation, or a cash-pay route, because the benefit itself leaves the drug out.
Match the denial reason to the fix — and to the proof to attach
| Denial reason | What it means | Evidence to attach |
|---|---|---|
| PA denied | A document was missing or didn’t meet the criteria | BMI, the weight-related condition, your comprehensive-program history |
| Non-formulary | Not on the preferred list, but an exception may exist | A letter of medical necessity explaining why Zepbound specifically |
| Excluded | Your employer’s benefit doesn’t cover the drug | Different fix — ask HR about exceptions; otherwise compare cash-pay |
| Wegovy preferred / step therapy | They want Wegovy tried first | Proof you tried Wegovy, or a documented reason you can’t use it |
| Quantity limit | A fill-amount issue, not a true denial | Have the pharmacy align your fill with the limit |
| Diagnosis path | Submitted under the wrong use | If it fits, resubmit under weight management or OSA with documentation |
How to appeal a denial, step by step:
- Get the written denial and find the reason
- Ask CVS Caremark for the exact PA or exception criteria
- Have your doctor decide if a resubmission, exception, or appeal fits your case
- Attach objective proof: BMI, your health conditions, weight history, any Wegovy trial or reaction, and — if it applies — your sleep-apnea diagnosis and AHI
- While you wait, look at cash-pay so you’re not stuck without medicine
One honest word
If your employer fully excludes weight-loss drugs, no telehealth service, coverage tool, or appeal can force them to cover something they chose to leave out. In that case, your real options are an HR conversation or a cash-pay route — and we’ll show you the cheapest legitimate one next.
Stuck at “denied” or “PA required” and don’t want to fight it alone? Ro’s insurance team can submit the prior-authorization paperwork when a Ro clinician prescribes and your plan requires it.
See if Ro can handle the paperwork →Sponsored. This does not guarantee your plan approves it.
How much does Zepbound cost with CVS Caremark — and without it?
| Route | Rough monthly cost | Who it fits | The catch |
|---|---|---|---|
| Covered by CVS Caremark + Lilly $25 savings card | As low as $25 | Commercial members whose plan covers Zepbound | Savings cap around $100/mo and $1,300/yr; not for Medicare/Medicaid; current card runs through end of 2026 |
| Covered, no savings card | Your plan’s copay/coinsurance | Members with coverage but no card eligibility | A high deductible can still mean a big first bill |
| Lilly self-pay (vial or KwikPen) | ~$299 (2.5mg), ~$399 (5mg), ~$449 (7.5–15mg) | People without usable coverage who want real Zepbound | Refill within 45 days to keep the $449 price; miss it and it’s $499 (7.5mg) or $699 (10–15mg); can’t bill insurance |
| Retail cash, no program | ~$1,086+ | Almost no one — last resort | Far more than Lilly’s own price |
| Compounded “tirzepatide” | Lower, but a separate topic | A different decision entirely | Not an FDA-approved finished medicine; we cover it on its own page, not here |
The $25 price needs coverage
Lilly’s savings card drops your cost to as little as $25 a month only if your commercial plan covers the Zepbound single-dose pen, and it doesn’t apply to government insurance like Medicare or Medicaid. If your plan doesn’t cover the pen, that $25 card won’t apply — but Lilly’s self-pay pricing (around $299–$449) still can.
The 45-day rule is real
For the higher doses (7.5mg and up), you keep the ~$449 price only if you refill within 45 days of your last shipment. Miss the window and that fill jumps to $499 (7.5mg) or $699 (10–15mg). Set a calendar reminder around day 30.
Before you assume a denial means paying $1,086…
Our quiz runs your situation against covered-copay, savings-card, and Lilly self-pay pricing so you can see the cheapest path for you.
Compare my real Zepbound costs →What if your CVS Caremark plan covers Wegovy instead of Zepbound?
Switching to Wegovy may make sense if:
- Your plan requires Wegovy first
- Zepbound is fully excluded on your plan
- You don’t have a sleep-apnea reason to need Zepbound specifically
- Your doctor agrees Wegovy is a good fit
Pushing for Zepbound may be worth it if:
- You have moderate-to-severe OSA
- You tried Wegovy and it didn’t work or you couldn’t tolerate it
- You’re already doing well on Zepbound and don’t want to interrupt progress
- Your doctor believes Zepbound is medically necessary for you
The good news after October 1: with both drugs on the preferred list, the choice is more about what’s right for your body and less about what your plan will tolerate. See our Zepbound vs. Wegovy comparison if you’re weighing the two.
Can Ro actually help with CVS Caremark Zepbound coverage?
We don’t ask you to take Ro’s word for it. Here’s what Ro states versus what we confirmed (June 2, 2026):
| What Ro states | What we verified | Source |
|---|---|---|
| Free GLP-1 Insurance Coverage Checker, with a personalized report | Live; collects your insurance info, works with your plan, sends a report; $50 credit for new accounts | ro.co |
| Carries Zepbound | Zepbound single-dose pen (insurance-checked, pick up locally) and KwikPen (cash-pay, shipped) | ro.co |
| Membership pricing | $39 first month, then as low as $74/mo with annual prepay (or $149/mo monthly); medication is separate | ro.co/weight-loss/pricing |
| Insurance concierge handles PA | Ro’s team files prior authorization when a Ro clinician prescribes; approval is never guaranteed | ro.co |
Who Ro is not for
If you just want a no-membership cash prescription and nothing else, you’ll likely prefer going straight to Lilly’s self-pay program or comparing other providers. That’s a fair choice, and we’d rather you find the right fit than feel boxed in.
Want help verifying coverage and the paperwork without the phone tag?
Check CVS Caremark GLP-1 coverage with Ro →Sponsored. Best for people who want hands-on help; not for those who only want a quick cash script.
Quick way to choose your route
- •Use Ro if you want a coverage check plus help with the prior-authorization paperwork.
- •Use Sesame Care if you want to pick your own provider and a transparent visit price for brand-name GLP-1s. Compare Sesame’s options →
- •Use Lilly’s self-pay if you already have a prescription and you’re paying cash.
Want a full lineup? See our best Zepbound providers that accept insurance.
Does Medicare (or Medicare Advantage) through CVS Caremark cover Zepbound?
When
July 1, 2026 through December 31, 2027 (a short-term pilot)
Cost
A flat $50 per month, no matter your dose — does not count toward your Part D deductible or your $2,100 annual out-of-pocket cap
What's covered
All forms of Foundayo and Wegovy (pills and injections), and only the KwikPen form of Zepbound. Single-dose vials and single-dose pens of Zepbound are NOT in the Bridge.
How it works
It runs separate from your Part D plan — your plan doesn't need to opt in. Your doctor sends the prior authorization to a CMS system.
Fine print
That $50 does not count toward your Part D deductible or your out-of-pocket cap, and low-income help (Extra Help) doesn't lower it.
Who qualifies for the Bridge
You must be enrolled in a Medicare Part D plan, and meet one of three groups (judged by your status when you started GLP-1 therapy):
- A BMI of 35 or higher, on its own; or
- A BMI of 30 or higher with heart failure with preserved ejection fraction, uncontrolled high blood pressure (despite two blood-pressure medicines), or chronic kidney disease stage 3a or above; or
- A BMI of 27 or higher with prediabetes, a previous heart attack, a previous stroke, or symptomatic peripheral artery disease
Important nuances
- A BMI of 30–34 on its own isn’t enough for the Bridge — you need either BMI 35+, or one of those conditions
- If you’re prescribed Zepbound for a reason Medicare already covers — like moderate-to-severe sleep apnea — that goes through your regular Part D plan, not the Bridge
If you’re on Medicare, don’t follow the commercial-plan steps above as if they apply to you. Check the Bridge rules first. For a full breakdown, see our Medicare GLP-1 Bridge guide.
What safety facts should you know before chasing coverage?
From Zepbound’s FDA-approved labeling:
- Don’t use it if you or a family member has had medullary thyroid cancer or a condition called MEN 2, or if you’ve had a serious allergic reaction to tirzepatide.
- Possible serious side effects include pancreatitis, gallbladder problems, kidney problems from dehydration, severe stomach and intestinal problems, and low blood sugar (especially if you also take certain diabetes medicines).
- Don’t combine Zepbound with other tirzepatide products or other GLP-1 medicines.
- Tell your clinician about pregnancy plans, your medical history, and any surgery coming up.
This isn’t the full label — read the Medication Guide and talk to your doctor. Coverage is a benefits question. Safety is a medical one.
How we verified this guide
We built this page from primary sources, not from other blogs. We read CVS Health’s May 2026 announcement, CVS Caremark’s own prior-authorization criteria, the FDA’s labeling, Eli Lilly’s pricing terms, and CMS’s Medicare GLP-1 Bridge pages — then we dated everything, because this stuff changes fast.
| Claim | Source | Confirmed |
|---|---|---|
| Zepbound returns to common CVS Caremark commercial formularies Oct. 1, 2026, for plans that elect coverage | CVS Health press release (May 28, 2026) | ✓ June 2, 2026 |
| Plan sponsors keep discretion to customize coverage | CVS Health press release | ✓ June 2, 2026 |
| 2025 removal from Standard Control / Advanced Control / Value lists; Wegovy preferred | CVS Caremark notices | ✓ June 1, 2026 |
| PA criteria: BMI ≥30 (or ≥27 + comorbidity); comprehensive program ~6 months; OSA path; renewal at 5% loss | CVS Caremark PA criteria | ✓ June 1, 2026 |
| Zepbound FDA-approved for moderate-to-severe OSA in adults with obesity | FDA | ✓ June 1, 2026 |
| Lilly self-pay $299/$399/$449; missed 45-day refill $499/$699; $25 card needs commercial coverage | Eli Lilly terms | ✓ June 2, 2026 |
| Ro carries Zepbound pen + KwikPen; free coverage checker; membership pricing | Ro | ✓ June 2, 2026 |
| Medicare GLP-1 Bridge: $50/mo, KwikPen only, three BMI groups, July 1, 2026–Dec. 31, 2027 | CMS | ✓ June 2, 2026 |
Last verified: We re-check the commercial facts on this page monthly through October 2026, and the clinical and regulatory sources quarterly.
Frequently asked questions about CVS Caremark and Zepbound
Does CVS Caremark cover Zepbound?
Not on its standard commercial lists right now -- Zepbound was removed on July 1, 2025. CVS Health says it returns as a preferred option on October 1, 2026 for plans that elect coverage, but your employer can still customize coverage and prior authorization may apply.
When will CVS Caremark cover Zepbound again?
CVS announced October 1, 2026 for its common commercial drug lists. Whether your specific plan covers it then depends on whether your employer adopts the updated list.
Why did CVS Caremark stop covering Zepbound?
CVS Caremark made Wegovy its preferred weight-loss drug in 2025 and removed Zepbound from its main lists effective July 1, 2025.
Will my employer plan automatically cover Zepbound after October 1?
Not necessarily. CVS says plan sponsors keep the right to customize coverage, so ask your HR or benefits team whether your plan adopted the change.
Does CVS Caremark require prior authorization for Zepbound?
Usually, yes. The criteria differ for weight management, sleep apnea, and renewals, and during the gap many plans want Wegovy tried first.
What BMI does CVS Caremark require for Zepbound?
For weight loss: a BMI of 30 or higher, or 27 or higher with a weight-related condition. For the sleep-apnea path: a BMI of 30 or higher plus a moderate-to-severe OSA diagnosis.
Does sleep apnea help get Zepbound covered?
It can. Zepbound is FDA-approved for moderate-to-severe obstructive sleep apnea in adults with obesity, which can open a separate coverage path -- but approval still depends on your plan's rules and your documentation.
What if CVS Caremark wants me to use Wegovy instead?
Talk to your doctor. Wegovy may be the required first step on your plan, but you can pursue a Zepbound exception if it's medically appropriate -- for example, if Wegovy didn't work or you have OSA.
Can I use the Zepbound savings card with CVS Caremark?
If you have commercial insurance that covers the Zepbound single-dose pen and you're eligible, Eli Lilly's savings card can lower your cost to as little as $25 a month. It isn't available for Medicare or Medicaid.
How much is Zepbound if CVS Caremark denies it?
Lilly's self-pay program starts around $299 a month and runs about $449 for higher doses (with a 45-day refill rule) -- well below the roughly $1,086 retail list price.
Can Ro guarantee CVS Caremark approval?
No. Ro can help check your coverage and file the prior-authorization paperwork when a Ro clinician prescribes, but no telehealth provider can guarantee your plan says yes.
Is compounded tirzepatide the same as Zepbound?
No. Zepbound is an FDA-approved, brand-name medicine; compounded tirzepatide is not an FDA-approved finished drug. They are not interchangeable.
Does Medicare change the answer?
Yes, completely. Medicare has its own rules. The new Medicare GLP-1 Bridge starts July 1, 2026 and covers the Zepbound KwikPen for eligible Part D members at $50 a month -- but Zepbound vials and single-dose pens are not included.
Still not sure which GLP-1 program is right for you?
Zepbound isn’t on most CVS Caremark standard plans today — it’s coming back October 1, 2026 for plans that elect it, and whether it reaches you depends on your employer and the right paperwork. You don’t have to figure that out alone, and you don’t have to pay $1,086 while you wait.
Take our free 60-second matching quiz. We’ll map your CVS Caremark situation to a clear next step — what to check, what to ask your doctor, and what it’ll really cost.
Start the free quiz →Sources
All sources last checked June 2, 2026.
- CVS Health -- Zepbound returns as preferred option announcement (May 28, 2026)
- CVS Caremark -- Zepbound prior-authorization criteria
- FDA -- Zepbound approval for obstructive sleep apnea
- DailyMed -- Zepbound (tirzepatide) labeling and Medication Guide
- Eli Lilly -- Zepbound self-pay and savings programs
- CMS -- Medicare GLP-1 Bridge information for beneficiaries
- Ro -- GLP-1 Insurance Coverage Checker
- Ro -- Weight loss program pricing